5-[(3Z)-3-[(6E)-6-ethylidene-4,5-dimethoxycyclohexa-2,4-dien-1-ylidene]prop-1-en-2-yl]-6-propyl-1,3-benzodioxole

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二苯乙烯类
• 英文名称: 5-[(3Z)-3-[(6E)-6-ethylidene-4,5-dimethoxycyclohexa-2,4-dien-1-ylidene]prop-1-en-2-yl]-6-propyl-1,3-benzodioxole
• 化学式: C₂₃H₂₆O₄
• 分子量: 366.4
• InChiKey: GKUUSLKWCBFYAZ-PTUSWSKOSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.7
• 重原子数：
  27
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  36.9
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• BERBERINE SALTS, URSODEOXYCHOLIC SALTS AND COMBINATIONS, METHODS OF PREPARATION AND APPLICATION THEREOF
  申请人：SHENZHEN HIGHTIDE BIOPHARMACEUTICAL, LTD.

  公开号：US20170037043A1

  公开（公告）日：2017-02-09

  The invention provides various novel compositions of berberine in combination with pharmacologically active organic acids, and related methods of their use in treating various diseases or disorders. The invention further provides various novel compounds prepared from berberine and pharmacologically active organic acids and prepared from ursodeoxycholic acid and pharmacologically active organic bases, and pharmaceutical compositions thereof, and methods of their preparation and therapeutic use in treating and/or preventing various diseases or disorders. The compounds and pharmaceutical compositions of the invention can be utilized to treat various diseases or disorders, such as diabetes, diabetic complications, dyslipidemia, hyperlipidemia, obesity, metabolic syndromes, pre-diabetes, atherosclerosis, heart diseases, neurodegenerative diseases, sarcopenia, muscle atrophy, inflammation, cancer and liver diseases and conditions such as fatty liver, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, cholestatic liver diseases or graft-versus-host disease of the liver. The compounds of this invention are also useful in improving liver functions in chronic viral associated liver diseases and alcohol-related liver diseases.
• US8710071B2
  申请人：——

  公开号：US8710071B2

  公开（公告）日：2014-04-29
• US8815900B2
  申请人：——

  公开号：US8815900B2

  公开（公告）日：2014-08-26